Skip to main content
Veterinary Medicines

Aftovaxpur DOE (18) O1 BFS + Asia1 Shamir

Authorised
  • Foot-and-mouth disease virus, serotype O, strain O1 BFS, Inactivated
  • Foot-and-mouth disease virus, serotype Asia 1, strain Shamir, Inactivated

Sainaithint táirge

Sonraí an táirge

Substaint ghníomhach / Láidreacht:
  • Ar fáil ach amháin i English
    Presentation_strength:≥ 6 PD50 Reference:Hse Index:0
  • Ar fáil ach amháin i English
    Presentation_strength:≥ 6 PD50 Index:11
Foirm chógaisíochta:
  • Eibleacht le haghaidh insteallta
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Not applicable
        0
        day
    • Sheep
      • Not applicable
        0
        day
    • Pig
      • Not applicable
        0
        day
  • Subcutaneous use
    • Cattle
      • Not applicable
        0
        day
    • Sheep
      • Not applicable
        0
        day
    • Pig
      • Not applicable
        0
        day
An cód tréidliachta ceimiceach teiripeach anatamaíoch (Cód ATCvet):
  • QI02AA04
Stádas údaraithe:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Tuairisc ar an bpacáiste:

Eolas breise

Entitlement type:
Sealbhóir an údaraithe margaíochta:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Láithreacha monaraíochta um eisiúint bhaisce:
  • Boehringer Ingelheim Animal Health France
An t-údarás atá freagrach:
  • European Commission
Uimhir údaraithe:
Níl an fhaisnéis seo ar fáil don táirge seo.
Athrú stádais maidir leis an dáta údaraithe:

Doiciméid

Combined File of all Documents

Níl an doiciméad seo ann sa teanga seo (Gaeilge). Is féidir leat é a fháil i dteanga eile thíos.
Bulgarian (PDF)
Foilsithe ar: 19/03/2024
Croatian (PDF)
Foilsithe ar: 19/03/2024
Czech (PDF)
Foilsithe ar: 19/03/2024
Danish (PDF)
Foilsithe ar: 19/03/2024
Dutch (PDF)
Foilsithe ar: 19/03/2024
English (PDF)
Foilsithe ar: 19/03/2024
Estonian (PDF)
Foilsithe ar: 19/03/2024
Finnish (PDF)
Foilsithe ar: 19/03/2024
French (PDF)
Foilsithe ar: 19/03/2024
German (PDF)
Foilsithe ar: 19/03/2024
Greek (PDF)
Foilsithe ar: 19/03/2024
Hungarian (PDF)
Foilsithe ar: 19/03/2024
Icelandic (PDF)
Foilsithe ar: 19/03/2024
Italian (PDF)
Foilsithe ar: 19/03/2024
Latvian (PDF)
Foilsithe ar: 19/03/2024
Lithuanian (PDF)
Foilsithe ar: 19/03/2024
Maltese (PDF)
Foilsithe ar: 19/03/2024
Norwegian (PDF)
Foilsithe ar: 19/03/2024
Polish (PDF)
Foilsithe ar: 19/03/2024
Portuguese (PDF)
Foilsithe ar: 19/03/2024
Romanian (PDF)
Foilsithe ar: 19/03/2024
Slovak (PDF)
Foilsithe ar: 19/03/2024
Slovenian (PDF)
Foilsithe ar: 19/03/2024
Spanish (PDF)
Foilsithe ar: 19/03/2024
Swedish (PDF)
Foilsithe ar: 19/03/2024

ema-puar-aftovaxpur-v-2292-par-en.pdf

English (PDF)
Foilsithe ar: 6/02/2023
Íoslódáil

ema-puar-aftovaxpur-v-2292-var-ii-0009-en.pdf

English (PDF)
Foilsithe ar: 6/02/2023
Íoslódáil

ema-puar-aftovaxpur-v-2292-var-ii-0001-en.pdf

English (PDF)
Foilsithe ar: 6/02/2023
Íoslódáil
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."